Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005789 | endoplasmic reticulum membrane | 4 | 2 |
GO:0005886 | plasma membrane | 3 | 2 |
GO:0016020 | membrane | 2 | 10 |
GO:0031090 | organelle membrane | 3 | 2 |
GO:0044232 | organelle membrane contact site | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
GO:0140268 | endoplasmic reticulum-plasma membrane contact site | 3 | 2 |
Related structures:
AlphaFold database: Q4QEC6
Term | Name | Level | Count |
---|---|---|---|
GO:0006810 | transport | 3 | 2 |
GO:0006869 | lipid transport | 5 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0015850 | organic hydroxy compound transport | 5 | 2 |
GO:0015918 | sterol transport | 6 | 2 |
GO:0032365 | intracellular lipid transport | 4 | 2 |
GO:0032366 | intracellular sterol transport | 5 | 2 |
GO:0046907 | intracellular transport | 3 | 2 |
GO:0051179 | localization | 1 | 2 |
GO:0051234 | establishment of localization | 2 | 2 |
GO:0051641 | cellular localization | 2 | 2 |
GO:0051649 | establishment of localization in cell | 3 | 2 |
GO:0071702 | organic substance transport | 4 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005215 | transporter activity | 1 | 2 |
GO:0005319 | lipid transporter activity | 2 | 2 |
GO:0005488 | binding | 1 | 2 |
GO:0005496 | steroid binding | 3 | 2 |
GO:0008289 | lipid binding | 2 | 2 |
GO:0015248 | sterol transporter activity | 3 | 2 |
GO:0032934 | sterol binding | 4 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:0120013 | lipid transfer activity | 3 | 2 |
GO:0120015 | sterol transfer activity | 4 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 201 | 205 | PF00656 | 0.607 |
CLV_MEL_PAP_1 | 285 | 291 | PF00089 | 0.564 |
CLV_NRD_NRD_1 | 258 | 260 | PF00675 | 0.548 |
CLV_NRD_NRD_1 | 78 | 80 | PF00675 | 0.270 |
CLV_PCSK_KEX2_1 | 258 | 260 | PF00082 | 0.483 |
CLV_PCSK_SKI1_1 | 102 | 106 | PF00082 | 0.305 |
CLV_PCSK_SKI1_1 | 125 | 129 | PF00082 | 0.270 |
CLV_PCSK_SKI1_1 | 325 | 329 | PF00082 | 0.508 |
CLV_PCSK_SKI1_1 | 55 | 59 | PF00082 | 0.310 |
DEG_APCC_DBOX_1 | 124 | 132 | PF00400 | 0.582 |
DOC_CDC14_PxL_1 | 131 | 139 | PF14671 | 0.421 |
DOC_CKS1_1 | 45 | 50 | PF01111 | 0.625 |
DOC_CYCLIN_yCln2_LP_2 | 45 | 51 | PF00134 | 0.504 |
DOC_MAPK_DCC_7 | 130 | 139 | PF00069 | 0.421 |
DOC_MAPK_DCC_7 | 43 | 51 | PF00069 | 0.531 |
DOC_MAPK_gen_1 | 299 | 308 | PF00069 | 0.401 |
DOC_MAPK_MEF2A_6 | 130 | 139 | PF00069 | 0.508 |
DOC_USP7_MATH_1 | 17 | 21 | PF00917 | 0.594 |
DOC_USP7_MATH_1 | 218 | 222 | PF00917 | 0.725 |
DOC_WW_Pin1_4 | 241 | 246 | PF00397 | 0.806 |
DOC_WW_Pin1_4 | 44 | 49 | PF00397 | 0.621 |
LIG_14-3-3_CanoR_1 | 102 | 110 | PF00244 | 0.495 |
LIG_14-3-3_CanoR_1 | 192 | 202 | PF00244 | 0.511 |
LIG_14-3-3_CanoR_1 | 251 | 257 | PF00244 | 0.587 |
LIG_14-3-3_CanoR_1 | 288 | 294 | PF00244 | 0.507 |
LIG_Actin_WH2_2 | 264 | 280 | PF00022 | 0.474 |
LIG_AP2alpha_1 | 150 | 154 | PF02296 | 0.495 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.618 |
LIG_CaM_NSCaTE_8 | 317 | 324 | PF13499 | 0.497 |
LIG_deltaCOP1_diTrp_1 | 83 | 89 | PF00928 | 0.520 |
LIG_EH1_1 | 153 | 161 | PF00400 | 0.475 |
LIG_eIF4E_1 | 123 | 129 | PF01652 | 0.582 |
LIG_FHA_1 | 105 | 111 | PF00498 | 0.481 |
LIG_FHA_1 | 134 | 140 | PF00498 | 0.473 |
LIG_FHA_1 | 263 | 269 | PF00498 | 0.470 |
LIG_FHA_1 | 281 | 287 | PF00498 | 0.255 |
LIG_FHA_1 | 67 | 73 | PF00498 | 0.561 |
LIG_FHA_2 | 117 | 123 | PF00498 | 0.552 |
LIG_FHA_2 | 234 | 240 | PF00498 | 0.745 |
LIG_FHA_2 | 4 | 10 | PF00498 | 0.672 |
LIG_LIR_Gen_1 | 22 | 31 | PF02991 | 0.555 |
LIG_LIR_Gen_1 | 279 | 289 | PF02991 | 0.598 |
LIG_LIR_Gen_1 | 36 | 46 | PF02991 | 0.539 |
LIG_LIR_Nem_3 | 119 | 123 | PF02991 | 0.470 |
LIG_LIR_Nem_3 | 22 | 27 | PF02991 | 0.571 |
LIG_LIR_Nem_3 | 279 | 284 | PF02991 | 0.558 |
LIG_LIR_Nem_3 | 316 | 320 | PF02991 | 0.501 |
LIG_LIR_Nem_3 | 337 | 342 | PF02991 | 0.473 |
LIG_LIR_Nem_3 | 343 | 347 | PF02991 | 0.658 |
LIG_LIR_Nem_3 | 36 | 41 | PF02991 | 0.537 |
LIG_MYND_1 | 245 | 249 | PF01753 | 0.759 |
LIG_PDZ_Class_1 | 347 | 352 | PF00595 | 0.665 |
LIG_Pex14_2 | 150 | 154 | PF04695 | 0.495 |
LIG_Pex14_2 | 61 | 65 | PF04695 | 0.481 |
LIG_SH2_STAT5 | 118 | 121 | PF00017 | 0.561 |
LIG_SH2_STAT5 | 180 | 183 | PF00017 | 0.561 |
LIG_SH2_STAT5 | 332 | 335 | PF00017 | 0.458 |
LIG_SH3_1 | 242 | 248 | PF00018 | 0.734 |
LIG_SH3_1 | 85 | 91 | PF00018 | 0.497 |
LIG_SH3_2 | 88 | 93 | PF14604 | 0.528 |
LIG_SH3_3 | 242 | 248 | PF00018 | 0.744 |
LIG_SH3_3 | 85 | 91 | PF00018 | 0.497 |
LIG_SUMO_SIM_anti_2 | 304 | 310 | PF11976 | 0.401 |
LIG_SUMO_SIM_par_1 | 282 | 287 | PF11976 | 0.457 |
LIG_SUMO_SIM_par_1 | 332 | 337 | PF11976 | 0.418 |
LIG_WRC_WIRS_1 | 159 | 164 | PF05994 | 0.528 |
MOD_CDK_SPxK_1 | 44 | 50 | PF00069 | 0.625 |
MOD_CK1_1 | 167 | 173 | PF00069 | 0.563 |
MOD_CK1_1 | 233 | 239 | PF00069 | 0.738 |
MOD_CK1_1 | 33 | 39 | PF00069 | 0.547 |
MOD_CK2_1 | 116 | 122 | PF00069 | 0.552 |
MOD_CK2_1 | 22 | 28 | PF00069 | 0.433 |
MOD_CK2_1 | 233 | 239 | PF00069 | 0.695 |
MOD_CK2_1 | 287 | 293 | PF00069 | 0.495 |
MOD_CK2_1 | 3 | 9 | PF00069 | 0.638 |
MOD_CMANNOS | 86 | 89 | PF00535 | 0.281 |
MOD_GlcNHglycan | 131 | 134 | PF01048 | 0.327 |
MOD_GlcNHglycan | 166 | 169 | PF01048 | 0.361 |
MOD_GlcNHglycan | 220 | 223 | PF01048 | 0.528 |
MOD_GlcNHglycan | 226 | 229 | PF01048 | 0.551 |
MOD_GlcNHglycan | 289 | 292 | PF01048 | 0.683 |
MOD_GlcNHglycan | 32 | 35 | PF01048 | 0.430 |
MOD_GlcNHglycan | 321 | 324 | PF01048 | 0.680 |
MOD_GSK3_1 | 129 | 136 | PF00069 | 0.589 |
MOD_GSK3_1 | 160 | 167 | PF00069 | 0.555 |
MOD_GSK3_1 | 193 | 200 | PF00069 | 0.520 |
MOD_GSK3_1 | 22 | 29 | PF00069 | 0.564 |
MOD_GSK3_1 | 233 | 240 | PF00069 | 0.654 |
MOD_GSK3_1 | 276 | 283 | PF00069 | 0.370 |
MOD_NEK2_1 | 104 | 109 | PF00069 | 0.501 |
MOD_NEK2_1 | 129 | 134 | PF00069 | 0.582 |
MOD_NEK2_1 | 183 | 188 | PF00069 | 0.547 |
MOD_NEK2_1 | 284 | 289 | PF00069 | 0.390 |
MOD_NEK2_1 | 3 | 8 | PF00069 | 0.617 |
MOD_NEK2_1 | 334 | 339 | PF00069 | 0.385 |
MOD_NEK2_2 | 171 | 176 | PF00069 | 0.508 |
MOD_NEK2_2 | 340 | 345 | PF00069 | 0.399 |
MOD_PIKK_1 | 140 | 146 | PF00454 | 0.561 |
MOD_PIKK_1 | 160 | 166 | PF00454 | 0.350 |
MOD_PIKK_1 | 22 | 28 | PF00454 | 0.644 |
MOD_PKA_1 | 79 | 85 | PF00069 | 0.481 |
MOD_PKA_2 | 287 | 293 | PF00069 | 0.508 |
MOD_PKA_2 | 89 | 95 | PF00069 | 0.521 |
MOD_Plk_1 | 171 | 177 | PF00069 | 0.565 |
MOD_Plk_1 | 36 | 42 | PF00069 | 0.539 |
MOD_Plk_4 | 105 | 111 | PF00069 | 0.481 |
MOD_Plk_4 | 116 | 122 | PF00069 | 0.478 |
MOD_Plk_4 | 183 | 189 | PF00069 | 0.528 |
MOD_Plk_4 | 276 | 282 | PF00069 | 0.356 |
MOD_Plk_4 | 309 | 315 | PF00069 | 0.346 |
MOD_ProDKin_1 | 241 | 247 | PF00069 | 0.803 |
MOD_ProDKin_1 | 44 | 50 | PF00069 | 0.625 |
MOD_SUMO_rev_2 | 73 | 82 | PF00179 | 0.512 |
MOD_SUMO_rev_2 | 8 | 16 | PF00179 | 0.668 |
TRG_ENDOCYTIC_2 | 118 | 121 | PF00928 | 0.510 |
TRG_ENDOCYTIC_2 | 126 | 129 | PF00928 | 0.443 |
TRG_ENDOCYTIC_2 | 180 | 183 | PF00928 | 0.561 |
TRG_ENDOCYTIC_2 | 332 | 335 | PF00928 | 0.431 |
TRG_ER_diArg_1 | 258 | 260 | PF00400 | 0.682 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4JTD3 | Bodo saltans | 26% | 82% |
A0A1X0NTC3 | Trypanosomatidae | 41% | 99% |
A0A3Q8IAW1 | Leishmania donovani | 93% | 100% |
A0A3R7N4K3 | Trypanosoma rangeli | 45% | 100% |
A0A3R7RDH3 | Trypanosoma rangeli | 45% | 100% |
A4H910 | Leishmania braziliensis | 79% | 98% |
A4HXE2 | Leishmania infantum | 93% | 100% |
E9AR37 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
V5BE10 | Trypanosoma cruzi | 43% | 99% |